Calendar

pharmadog

Week of Feb 2, 2026

Feb 3, 2026approval207d agoATELVIA (RISEDRONATE SODIUM) — FDA approvalAllergan Finance LLC

Sponsor: APIL. Form: TABLET, DELAYED RELEASE. Route: ORAL

full page →fda approvals ↗

Feb 3, 2026approval207d agoRECLAST (ZOLEDRONIC ACID) — FDA approvalZOLEDRONIC ACID

Sponsor: SANDOZ. Form: INJECTABLE. Route: INTRAVENOUS

full page →ZOLEDRONIC ACID →fda approvals ↗

Feb 3, 2026approval207d agoDYNA-HEX 4 (CHLORHEXIDINE GLUCONATE) — FDA approvalCoorg Instituite of Dental Sciences

Sponsor: XTTRIUM. Form: SOLUTION. Route: TOPICAL

full page →fda approvals ↗

Feb 3, 2026approval207d agoIBANDRONATE SODIUM — FDA approvalDR REDDYS LABORATORIES LTD

Sponsor: AVET LIFESCIENCES. Form: INJECTABLE. Route: INTRAVENOUS

full page →fda approvals ↗

Feb 3, 2026approval207d agoFOSAMAX (ALENDRONATE SODIUM) — FDA approvalALENDRONATE SODIUM

Sponsor: ORGANON. Form: TABLET. Route: ORAL

full page →ALENDRONATE SODIUM →fda approvals ↗

Feb 3, 2026approval207d agoIBANDRONATE SODIUM — FDA approvalDR REDDYS LABORATORIES LTD

Sponsor: SUN PHARM. Form: INJECTABLE. Route: INTRAVENOUS

full page →fda approvals ↗

Feb 3, 2026approval207d agoIBANDRONATE SODIUM — FDA approvalDR REDDYS LABORATORIES LTD

Sponsor: SUN PHARM. Form: INJECTABLE. Route: INTRAVENOUS

full page →fda approvals ↗

Feb 3, 2026approval207d agoALENDRONATE SODIUM — FDA approvalALENDRONATE SODIUM

Sponsor: HIKMA. Form: SOLUTION. Route: ORAL

full page →ALENDRONATE SODIUM →fda approvals ↗

Feb 3, 2026approval207d agoPREGABALIN — FDA approvalPREGABALIN

Sponsor: MSN. Form: TABLET, EXTENDED RELEASE. Route: ORAL

full page →PREGABALIN →fda approvals ↗

Feb 3, 2026approval207d agoSELENIOUS ACID — FDA approvalRK Pharma Inc

Sponsor: KINDOS. Form: SOLUTION. Route: INTRAVENOUS

full page →fda approvals ↗

Feb 3, 2026approval207d agoVYKOURA (LEUCOVORIN CALCIUM) — FDA approvalLEUCOVORIN CALCIUM

Sponsor: AVYXA HOLDINGS. Form: SOLUTION. Route: INTRAMUSCULAR, INTRAVENOUS

full page →LEUCOVORIN CALCIUM →fda approvals ↗

Feb 3, 2026approval207d agoIBANDRONATE SODIUM — FDA approvalIBANDRONATE SODIUM

Sponsor: APOTEX INC. Form: TABLET. Route: ORAL

full page →IBANDRONATE SODIUM →fda approvals ↗

Feb 3, 2026approval207d agoIBANDRONATE SODIUM — FDA approvalIBANDRONATE SODIUM

Sponsor: AUROBINDO PHARMA. Form: TABLET. Route: ORAL

full page →IBANDRONATE SODIUM →fda approvals ↗

Feb 3, 2026approval207d agoDYNA-HEX 2 (CHLORHEXIDINE GLUCONATE) — FDA approvalCoorg Instituite of Dental Sciences

Sponsor: XTTRIUM. Form: SOLUTION. Route: TOPICAL

full page →fda approvals ↗

Feb 3, 2026approval207d agoALENDRONATE SODIUM — FDA approvalALENDRONATE SODIUM

Sponsor: NOVITIUM PHARMA. Form: SOLUTION. Route: ORAL

full page →ALENDRONATE SODIUM →fda approvals ↗

Feb 3, 2026approval207d agoIBANDRONATE SODIUM — FDA approvalIBANDRONATE SODIUM

Sponsor: ACCORD HLTHCARE. Form: INJECTABLE. Route: INTRAVENOUS

full page →IBANDRONATE SODIUM →fda approvals ↗

Feb 3, 2026approval207d agoIBANDRONATE SODIUM — FDA approvalIBANDRONATE SODIUM

Sponsor: MACLEODS PHARMS LTD. Form: TABLET. Route: ORAL

full page →IBANDRONATE SODIUM →fda approvals ↗

Feb 3, 2026approval207d agoIBANDRONATE SODIUM — FDA approvalDR REDDYS LABORATORIES LTD

Sponsor: PHARMOBEDIENT. Form: TABLET. Route: ORAL

full page →fda approvals ↗

Feb 3, 2026approval207d agoIBANDRONATE SODIUM — FDA approvalIBANDRONATE SODIUM

Sponsor: SUN PHARM INDUSTRIES. Form: TABLET. Route: ORAL

full page →IBANDRONATE SODIUM →fda approvals ↗

Feb 3, 2026approval207d agoIBANDRONATE SODIUM — FDA approvalIBANDRONATE SODIUM

Sponsor: DR REDDYS LABS LTD. Form: TABLET. Route: ORAL

full page →IBANDRONATE SODIUM →fda approvals ↗

Feb 3, 2026approval207d agoIBANDRONATE SODIUM — FDA approvalDR REDDYS LABORATORIES LTD

Sponsor: ORBION PHARMS. Form: TABLET. Route: ORAL

full page →fda approvals ↗

Feb 3, 2026approval207d agoIBANDRONATE SODIUM — FDA approvalDR REDDYS LABORATORIES LTD

Sponsor: PHARMOBEDIENT. Form: INJECTABLE. Route: INTRAVENOUS

full page →fda approvals ↗

Feb 3, 2026approval207d agoIBANDRONATE SODIUM — FDA approvalDR REDDYS LABORATORIES LTD

Sponsor: WATSON LABS TEVA. Form: TABLET. Route: ORAL

full page →fda approvals ↗

Feb 3, 2026approval207d agoIBANDRONATE SODIUM — FDA approvalDR REDDYS LABORATORIES LTD

Sponsor: EUGIA PHARMA. Form: INJECTABLE. Route: INTRAVENOUS

full page →fda approvals ↗

Feb 3, 2026approval207d agoBINOSTO (ALENDRONATE SODIUM) — FDA approvalOrganon & Co.

Sponsor: RADIUS. Form: TABLET, EFFERVESCENT. Route: ORAL

full page →fda approvals ↗

Feb 3, 2026approval207d agoIBANDRONATE SODIUM — FDA approvalIBANDRONATE SODIUM

Sponsor: APOTEX. Form: INJECTABLE. Route: INTRAVENOUS

full page →IBANDRONATE SODIUM →fda approvals ↗

Feb 3, 2026approval207d agoIBANDRONATE SODIUM — FDA approvalIBANDRONATE SODIUM

Sponsor: APOTEX. Form: INJECTABLE. Route: INTRAVENOUS

full page →IBANDRONATE SODIUM →fda approvals ↗

Feb 3, 2026approval207d agoSTIVARGA (REGORAFENIB) — FDA approvalBayer AG

Sponsor: BAYER HLTHCARE. Form: TABLET. Route: ORAL

full page →fda approvals ↗

Feb 3, 2026approval207d agoDOXORUBICIN HYDROCHLORIDE — FDA approvalBAXTER INTERNATIONAL INC

Sponsor: QILU PHARM HAINAN. Form: INJECTABLE, LIPOSOMAL. Route: INJECTION

full page →fda approvals ↗

Feb 3, 2026approval207d agoACTONEL (RISEDRONATE SODIUM) — FDA approvalAllergan Finance LLC

Sponsor: APIL. Form: TABLET. Route: ORAL

full page →fda approvals ↗

Feb 3, 2026approval207d agoFOSAMAX PLUS D (ALENDRONATE SODIUM) — FDA approval(alendronate sodium + cholecalciferol)

Sponsor: ORGANON LLC. Form: TABLET. Route: ORAL

full page →(alendronate sodium + cholecalciferol) →fda approvals ↗

Feb 3, 2026approval207d agoIBANDRONATE SODIUM — FDA approvalDR REDDYS LABORATORIES LTD

Sponsor: NANG KUANG PHARM CO. Form: INJECTABLE. Route: INTRAVENOUS

full page →fda approvals ↗

Feb 3, 2026grant207d agoUNIVERSITY OF PENNSYLVANIA — SHIV-infected rhesus macaques as a model for HIV-1 bNAb developmentUniversity of Pennsylvania

AI grant. $803,591. PI: GEORGE M SHAW

full page →nih reporter ↗

Feb 3, 2026grant207d agoUNIVERSITY OF MICHIGAN AT ANN ARBOR — Deciphering Virulence Determinants of Human-Pathogenic Atypical Toxoplasma go...

AI grant. $411,780. PI: Yifan Wang

full page →nih reporter ↗

Feb 3, 2026grant207d agoUNIVERSITY OF FLORIDA — Detection of Shigella Species in Wastewater - A Pilot Study for Community and...University of Florida

AI grant. $422,125. PI: Anthony T Maurelli

full page →nih reporter ↗

Feb 3, 2026grant207d agoMETHODIST HOSPITAL RESEARCH INSTITUTE — The epigenetic regulation of alloimmune stem-like CD4+ T cells

AI grant. $491,663. PI: Wenhao Chen

full page →nih reporter ↗

Feb 3, 2026grant207d agoSLOAN-KETTERING INST CAN RESEARCH — Decoding the role of Aire-expressing Thetis cells in peripheral self-tolerance

AI grant. $616,042. PI: Chrysothemis Brown

full page →nih reporter ↗

Feb 3, 2026grant207d agoGEORGE WASHINGTON UNIVERSITY — Genetic determinants of host immunity-mediated resistance to helminth infection

AI grant. $444,125. PI: PEDRO GAZZINELLI GUIMARAES

full page →nih reporter ↗

Feb 3, 2026grant207d agoHUGO W. MOSER RES INST KENNEDY KRIEGER — GLOW: Gleaning Language trajectories and Outcomes in autistic toddlers using ...

DC grant. $818,502. PI: Rachel Reetzke

full page →nih reporter ↗

Feb 3, 2026grant207d agoUNIVERSITY OF FLORIDA — The role of B cell Cul4b in gammaherpesvirus latency and lymphomaUniversity of Florida

AI grant. $610,971. PI: Emily K. Moser

full page →nih reporter ↗

Feb 3, 2026grant207d agoUNIVERSITY OF CALIFORNIA, SAN FRANCISCO — Resilience in Action™ : Assessing the behavioral target mechanisms of the RiA...University of California San Francisco

MH grant. $863,276. PI: Megumi J Okumura

full page →nih reporter ↗

Feb 3, 2026grant207d agoUNIVERSITY OF CALIFORNIA LOS ANGELES — Deficits in behavioral time-scale plasticity underlying imprecision and insta...University of California Los Angeles

NS grant. $236,250. PI: Ahmet ARAC

full page →nih reporter ↗

Feb 3, 2026grant207d agoRUTGERS BIOMEDICAL AND HEALTH SCIENCES — Contribution of type III Interferons to the pathogenesis of Staphylococcus au...

AI grant. $762,847. PI: Dane Parker

full page →nih reporter ↗

Feb 3, 2026grant207d agoVANDERBILT UNIVERSITY — Engineering Extracellular Vesicles for Tolerogenic Immunotherapy

AI grant. $448,089. PI: John Tanner Wilson

full page →nih reporter ↗

Feb 3, 2026grant207d agoHENRY FORD HEALTH + MICHIGAN STATE UNIVERSITY HEALTH SCIENCES — Computationally predicting bacterial strain susceptibility to phages

AI grant. $435,379. PI: Janani Ravi

full page →nih reporter ↗

Feb 3, 2026grant207d agoSTATE UNIVERSITY OF NEW YORK AT ALBANY — A-rich function for the Zika virus 3' untranslated region

AI grant. $227,115. PI: Cara Theresia Pager

full page →nih reporter ↗

Feb 3, 2026grant207d agoICAHN SCHOOL OF MEDICINE AT MOUNT SINAI — A Comprehensive Genetic, Transcriptomic, and Immunohistochemical Analysis of PSP

NS grant. $669,891. PI: Kurt William Farrell

full page →nih reporter ↗

Feb 3, 2026grant207d agoTEXAS TECH UNIVERSITY — Population dynamics at an invasive front: Aedes aegypti in the American South...

AI grant. $648,891. PI: Joseph Richard McMillan

full page →nih reporter ↗

Feb 3, 2026grant207d agoMASSACHUSETTS GENERAL HOSPITAL — A tissue-based approach to understanding TB-associated lung fibrosisMassachusetts General Hospital

AI grant. $798,107. PI: Amy K Barczak

full page →nih reporter ↗

Feb 3, 2026grant207d agoUNIVERSITY OF CALIFORNIA, SAN DIEGO — Investigating the Role of Tanycyte Barriers at the Circumventricular Organs i...University of California San Diego

NS grant. $121,554. PI: Sidar Aydin

full page →nih reporter ↗

← prev

page 1 of 53

Week of Feb 2, 2026